Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease
Phase 1
Completed
- Conditions
- Pulmonary FibrosisThyroid Eye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Lassen Therapeutics 1 PTY LTD
- Target Recruit Count
- 75
- Registration Number
- NCT05331300
- Locations
- 🇦🇺
Site AU05, Hurstville, New South Wales, Australia
🇦🇺Site AU03, Brisbane, Queensland, Australia
🇦🇺Site AU01, Melbourne, Victoria, Australia
News
No news found